Militello John's Form 4 filing
Rocket Pharmaceuticals, Inc. (RCKT) · filed Mar 25, 2024
- Accession no.
- 0001140361-24-015101
- Filed
- Mar 25, 2024
- Trade date
- Feb 14, 2022-Mar 21, 2024
- Filing delay
- 770 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $70.0K. It was filed 770 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Militello JohnCIK 0001662170 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | JOtherAcquired | +2,903 | $0.00 | $0 | 24,420 | Direct | |
| Apr 18, 2022 | Common Stock | JOtherAcquired | +7,932 | $0.00 | $0 | 32,352 | Direct | |
| Aug 12, 2022 | Common Stock | JOtherAcquired | +14,310 | $0.00 | $0 | 46,662 | Direct | |
| Feb 14, 2023 | Common Stock | JOtherAcquired | +11,067 | $0.00 | $0 | 57,729 | Direct | |
| Mar 21, 2024 | Common Stock | SSaleDisposed | −2,490 | $28.10 | −$69,969 | 55,239 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | JOtherAcquired | +2,903 | $0.00 | $0 | 0 | Direct | |
| Apr 18, 2022 | Common Stock | JOtherAcquired | +7,932 | $0.00 | $0 | 0 | Direct | |
| Aug 12, 2022 | Common Stock | JOtherAcquired | +14,310 | $0.00 | $0 | 0 | Direct | |
| Feb 14, 2023 | Common Stock | JOtherAcquired | +2,903 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
VP, Principal Accounting Officer and Interim Principal Financial Officer